Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 6, 2005 - Issue 5
Submit an article Journal homepage
132
Views
9
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Sildenafil for the treatment of altitude-induced hypoxaemia

RICHALET J-P, GRATADOUR P, ROBACH P et al.: Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension. Am. J. Respir. Crit. Care. Med. (2005) 171:275-281 [1].

Petros PerimenisMedical School University of Patras, 26500 Rio, PatrasGreeceE-mail: [email protected]
Pages 835-837 | Published online: 10 May 2005

Bibliography

  • RICHALET J-P, GRATADOUR P, ROBACH P et al: Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension. Am. I Respir. Grit. Care Med. (2005) 171:275–281.
  • HACKETT PH, ROACH RC: High-altitude illness. N Engl. I Med. (2001) 345:107–114.
  • RICH S, KAUFMANN E, LEVY PS: Theeffect of high doses of calcium channel blockers on survival in primary pulmonary hypertension. N Engl. I Med. (1992) 327:76–81.
  • BARST RJ, RUBIN LJ, LONG WA et al: A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl. J. Med. (1996) 334:296–302.
  • RUBIN LJ, BADESCH DB, BARST RJ et al.: Bosentan therapy for pulmonary artery hypertension. N Engl. J. Med. (2002) 346:896–903.
  • GALIE N, HUMBERT M, VACHIERY JL, for the Arterial Pulmonary Hypertension and Beraprost European (ALPHABET) Study Group: Effect of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension. A randomized double blind placebo controlled trial. ./. Am. Coll. Cal-dial (2002) 39:1496–1502.
  • OLSCHEWSKI H, SIMONNEAU G, GALIE N, for the Aerosolized Iloprost Randomized Study Group: Inhaled iloprost in severe pulmonary hypertension. N Engl. J. Med. (2002) 347:322–329.
  • SASTRY BKS, NARASIMHAN C, KRISHNA REDDY N, SOMA RAJU B: Clinical efficacy of sildenafil in primary pulmonary hypertension. A randomized, placebo-controlled, double-blind, crossover study. J. Am. Coll. Cat-dial (2004) 43:1149–1153.
  • GHOFRANI HA, REICHENBERGER F,KOHSTALL MG et al.: Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial. Ann. Intern. Med. (2004) 141:169–177.
  • DISHY V, SOFOWORA G, HARRIS PA et al: The effect of sildenafil on nitric oxide-mediated vasodilation in healthy men. Clin. Pharmacol Ther. (2001) 70:270–279.
  • SANCHEZ LS, DE LA MONTE SM, FILIPPOV G et al: Cyclic-GMP-binding, cyclic-GMP-specific phosphodiesterase (PDE5) gene expression is regulated during rat pulmonary development. Pediatr. Res. (1998) 43:163–168.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.